Astec Lifesciences
ASTECNSE

Astec Lifesciences

₹694.70-5.70 (0.81%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
681.25
Today’s high
706.95
52 week low
513.40
52 week high
990.82
Open price
700.00
Previous close
700.40
Live volume
52,357
Lower circuit
555.80
Upper circuit
833.60

Fundamentals

Market Cap
₹1,554Cr
ROE
-20.72%
P/E Ratio(TTM)
-17.67
EPS(TTM)
-36.30
P/B Ratio
3.98
Dividend Yield
0.00%
Industry P/E
27.89
Book Value
175.30
Debt to Equity
1.15
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹161
+28.45%
Profit (Cr)
-₹7.75
+50.61%
-50062.5125187.5
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+34%
3Y CAGR-17%
Profit growthValue
1Y (TTM)+107%

About

Astec LifeSciences is a key manufacturer of agrochemical ingredients and intermediate products, serving both Indian and global markets with a balanced sales mix. The company's core value is to create delight for its customers, placing them at the heart of everything it does to deliver great value. It has successfully established itself as a global leader in the production and supply of Triazole Fungicides, a vital crop protection chemical.;
CEO/MD
Mr. Anurag Roy
Founded in
--
NSE symbol
ASTEC

Shareholding Pattern

Jun '25
Jul '25
Sep '25
Dec '25
Mar '26
Promoters
71.97%
Retail And Others
24.67%
Mutual Funds
3.02%
Other Domestic Institutions
0.32%
Foreign Institutions
0.02%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,079.65
+23.80 (2.25%)
L
    H
    4,862.3716.373.47
    ₹525.80
    +1.50 (0.29%)
    L
      H
      4,607.4230.688.38
      ₹77.91
      -0.34 (0.43%)
      L
        H
        3,827.0119.651.49
        ₹161.32
        +1.91 (1.20%)
        L
          H
          3,779.64-885.45
          Livesquawk
          Astec Lifesciences' Q4 net loss narrows to ₹77.5M vs ₹161M YoY. Q4 revenue rises to ₹1.59B compared to ₹1.2B YoY.
          2026
          27
          Apr
          Annual Result
          Release date
          30
          Jan
          Quarterly Result
          Release date
          2025
          29
          Oct
          Quarterly Result
          Release date
          28
          Jul
          Quarterly Result
          Release date

          4
          Jul
          Rights Entitlement
          Ex date
          1:7
          Ratio

          1 rights eligible for every 7 existing shares held
          Ratio1:7
          Offer price₹890.00
          Ex date4 Jul ‘25
          Record date4 Jul ‘25
          Announcement date30 Jun ‘25

          30
          Jun
          Rights Entitlement
          Announced
          1:7
          Ratio

          1 rights eligible for every 7 existing shares held
          Ratio1:7
          Offer price₹890.00
          Ex date4 Jul ‘25
          Record date4 Jul ‘25
          Announcement date30 Jun ‘25
          Events calendar
          View upcoming events in other stocks